FDA Inspection
Boehringer Ingelheim Pharma Gmbh & Co KgBoehringer Ingelheim Pharma Gmbh & Co Kg – FDA Inspection, Mar 19, 2013
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Pharma Gmbh & Co Kg, with an inspection on March 19, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 19, 2013
- Product Type
- Drugs
View Company Profile
ID · b82b9c1c-8e5d-4af2-b32e-7c891abab0fd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 826498
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Boehringer Ingelheim Pharma Gmbh & Co Kg
13| Date | Classification | Office | Project area |
|---|---|---|---|
| July 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 15, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 19, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Boehringer Ingelheim Pharma Gmbh & Co Kg
- FDA Inspection 1208927 - 2022-07-22
- FDA Inspection 1102691 - 2019-09-19
- FDA Inspection 1107587 - 2019-08-15
- FDA Inspection 1086418 - 2019-04-05
- FDA Inspection 1072835 - 2018-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.